Jagsonpal Pharmaceuticals Acquires Group Pharma’s Wellness Portfolio for up to ₹46.7 Crores
Jagsonpal Pharmaceuticals Ltd · Press Release · 23 Sept 2026, 11:32 pm
Jagsonpal Pharmaceuticals Acquires Group Pharma’s Wellness Portfolio for up to ₹46.7 Crores Jagsonpal Pharmaceuticals executed a Business Transfer Agreement on 23rd Sep'26 to acquire the Wellness Portfolio of Group Pharmaceuticals via slump sale. The target portfolio generated ₹24.6 crore turnover in FY'26 and strengthens Jagsonpal’s footprint in women’s healthcare. The transaction includes an initial cash consideration of ₹23.7 crore at closing, with performance-linked consideration of up to ₹23.0 crore tied to FY'28 sales, capping total payout at ₹46.7 crore. The acquisition requires no regulatory approvals and is slated for completion on or before 1st Nov'26.
Original exchange filing (PDF)
More announcements from Jagsonpal Pharmaceuticals Ltd
- Earning call transcript for Jagsonpal Pharmaceuticals Limited Q2 FY 27 Earning Conference Call on October 29, 2026 at 2:00 P.M · 03 Nov 2026
- Audio Recording of Jagsonpal Pharmaceuticals Limited Q2 FY27 Earnings Conference call on October 29, 2026 at 02:00 P.M. · 29 Oct 2026
- Press Release for Unaudited Financial Results for the quarter September 30, 2026 · 29 Oct 2026
- Press Release for Unaudited Financial Results for the quarter ended September 30, 2026. · 29 Oct 2026
- Unaudited Financial Results (Standalone & Consolidated for the quarter and half year ended September 30, 2026. · 28 Oct 2026
- Jagsonpal Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 28 Oct 2026
- Outcome of Board Meeting held on October 28, 2026 along with Unaudited Financial Results(Standalone & Consolidated) for the quarter and half year ended September 30, 2026 · 28 Oct 2026
- JAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 28-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 28 Oct 2026
